Since reading The Body Keeps the Score and following the work of pain scientists like Dr. Rachel Zoffness, I’ve been interested in learning more about a holistic approach to healing. Holistic meaning treating the whole person, not a singular body part. I became fascinated by how our mental landscape shapes our physical reality, and how some plant medicines have been shown to improve clinical outcomes. I’ve even been thinking about doing an Ayahuasca retreat to explore my own healing further.

It was this personal interest that led me to a recent information session on Psychedelic-Assisted Therapy. That, and the fact that I‘ve done so much therapy, most of which hasn’t helped me much at all.

While the word “psychedelic” might conjure up images of 1960s festivals, the modern clinical research, especially coming out of institutions like Cambridge University and the NHS, is focused on something much more profound: the psychological “reset” of the human mind.

What exactly are we talking about?

The word psychedelic is derived from the Greek psyche (mind, soul) and deloun (to reveal or manifest), literally translating as “mind-manifesting” or “soul-revealing”. These are substances that change how our brain communicates, allowing us to see patterns, memories, and emotions from a new perspective. In a clinical setting, these aren’t just “drugs”, but tools that can be used alongside intensive psychotherapy.

The “Classic” psychedelics include:

• Psilocybin: Found in magic mushrooms.
• DMT / Ayahuasca: A powerful plant-based brew.
• LSD: A synthetic compound known for its long duration.
• Mescaline: Derived from certain cacti.

There are also “non-classic” substances like MDMA (often called ecstasy) and Ketamine, which are being used to help people process deep-seated trauma without the usual “fight or flight” response getting in the way.

Understanding the “Whole” of health

To understand why this therapy is so exciting, we have to look at the Biopsychosocial model. It’s a big word for a simple idea: our health is a “whole” system.

• Bio (Biological): What’s happening in your cells, like inflammation in UC or Endometriosis.
• Psycho (Psychological): Your thoughts, emotions, and past traumas.
• Social: Your environment, your support system, and your stress levels.
• Spiritual: Your sense of meaning and connection to the world.

These aren’t separate boxes; they are all connected. If the “psychological” part of you is stuck in a loop of medical trauma or depression, your “biological” self stays on high alert. This keeps your nervous system in survival mode, which makes it physically harder for your body to regulate immunity or lower inflammation. By healing the mind, we give the body the safety it needs to function better.

The evidence: What the research says

The slides from the session I attended show that we are no longer in the “experimental” phase; we are seeing hard evidence of therapeutic potential across a range of conditions:

1. PTSD and MDMA. A landmark Phase 3 trial found that 67% of participants who received MDMA-assisted therapy no longer met the criteria for a PTSD diagnosis after just three sessions. That is an incredible success rate compared to traditional therapies.

2. OCD and Psilocybin. Recent developments at Cambridge and through the NHS are looking at how low-dose psilocybin can help with OCD. The goal here isn’t a “trip,” but rather increasing neuroplasticity – the brain’s ability to create new, healthier pathways and break free from obsessive loops.

3. The Dosing Experience This isn’t a quick pill. The slides highlighted that a dosing session is a significant time commitment:

• MDMA sessions: 6–8 hours.
• Psilocybin sessions: 4–6 hours.
• IV Ketamine: Approx. 40 minutes.

These sessions are bookended by “Preparation” and “Integration” meetings, where therapists help you make sense of the experience and apply it to your daily life.

The UK timeline

We often think of this as a “US thing,” but the UK is right at the forefront. Looking at the research timeline, we are currently in a massive surge of trials (2024–2026). This includes:

• IMPACT-1: Looking at Methylone for PTSD.
• COMPASS006: Focusing on Treatment-Resistant Depression.
• PSiGAD: Using Psilocybin for Generalised Anxiety Disorder.

A new light at the end of the tunnel?

While the focus of this research is firmly on psychological health, the ripple effect for those of us with chronic physical conditions is huge. If we can use these tools to process the “medical trauma” that so many of us carry, we might finally be able to move our bodies out of that permanent “fight or flight” state. Potentially reducing flares and the experience of chronic pain disorders.

It’s about more than just feeling happier; it’s about giving our nervous systems the chance to finally rest, which is the only state where true healing can happen.

I realise that the idea of receiving some of these psychedelics might seem scary to some people, but I’m interested to know, did you know about this research? Is this something you’ve looked into before, or is it something you might want to go away and learn more about now? Or does it all just feel a bit too far out for you? 🍵🌿